Solitary demyelinating plaques mimicking brain tumors: A tricky similarity

Journal of Postgraduate Medicine

Volumn 56, Issue 4, 2010, Pages 254-256

  Bacigaluppi, S ^a,b   Bacigaluppi, M ^c   Tredici, G ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b CTO HOSPITAL   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TUMOR; CLINICAL FEATURE; DEMYELINATING DISEASE; DEMYELINATION; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; EDITORIAL; HISTOPATHOLOGY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMEFACTIVE DEMYELINATING PLAQUE;

BRAIN NEOPLASMS; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; GLIOMA; HUMANS;

EID: 77958005025     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.70928     Document Type: Editorial

References (14)

1. Leonhard R. Aeonen des Fegefeuers. Aphorismen. 1ed. Leipzig: Kurt Wolff Verlag; 1917.
2. Garg RK, Sinha MK. Multiple ring-enhancing lesions of the brain. J Postgrad Med 2010;56,307-16.
3. Poser CM, Goutières F, Carpentier MA, Aicardi J. Schilder's myelinoclastic diffuse sclerosis. Pediatrics 1986;77:107-12.
4. Paty DW, Oger JJ, Kastrukoff L F, Hashimoto SA, Hooge J P, Eisen AA, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988;38:180-5.
5. Lucchinetti C F, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 2008;131:1759-75.
6. Bacigaluppi S, Polonara G, Zavanone ML, Campanella R, Branca V, Gaini SM, Tredici G, Costa A., Schilder's disease: non-invasive diagnosis? A case report and review. Neurological Sciences (2009), 30(5), page:421-30, DOI: 10.1007/s10072-009-0113-z,
7. Poser CM, Goutières F, Carpentier MA, Aicardi J. Schilder's Myelinoclastic diffuse sclerosis. Pediatrics 1986;77:1-60.
8. Fallah A, Banglawala S, Ebrahim S, Paulseth JE, Jha NK. Case Series: tumefactive demyelinating lesions: a diagnostic challenge. Can J Surg 2010;53:69-70.
9. Malhotra HS, Jain KK, Agarwal A, Singh MK, Yadav SK, Husain M, et al. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy. Mult Scler 2009;15:193-203.
10. Van Everdingen KJ, van der Grond J, Kappelle LJ, Ramos LM, Mali W P. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke 1998;29:1783-90.
11. Reddy JS, Mishra AM, Behari S, Husain M, Gupta V, Rastogi M, et al. The role of diffusion-weighted imaging in the differential diagnosis of intracranial cystic mass lesions: a report of 147 lesions. Surg Neurol 2006;66:246-50.
12. Cianfoni A, Niku S, Imbesi SG. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy. AJNR Am J Neuroradiol 2007;28:272-7.
13. Jain R, Ellika S, Lehman NL, Scarpace L, Schultz LR, Rock J P, et al. Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT? J Neurooncol 2009.
14. Akimoto J, Nakajima N, Saida A, Haraoka J, Kudo M. Monofocal acute inflammatory demyelination manifesting as open ring sign. Case report. Neurol Med Chir 2006;46:353-7.